The recent identification of highly divergent influenza A viruses in bats revealed a new, geographically dispersed viral reservoir. To investigate the molecular mechanisms of host-restricted viral tropism and the potential for transmission of viruses between humans and bats, we exposed a panel of cell lines from bats of diverse species to a prototypical human-origin influenza A virus. All of the tested bat cell lines were susceptible to influenza A virus infection. Experimental evolution of human and avian-like viruses in bat cells resulted in efficient replication and created highly cytopathic variants. Deep sequencing of adapted human influenza A virus revealed a mutation in the PA polymerase subunit not previously described, M285K. Recombinant virus with the PA M285K mutation completely phenocopied the adapted virus. Adaptation of an avian virus-like virus resulted in the canonical PB2 E627K mutation that is required for efficient replication in other mammals. None of the adaptive mutations occurred in the gene for viral hemagglutinin, a gene that frequently acquires changes to recognize host-specific variations in sialic acid receptors. We showed that human influenza A virus uses canonical sialic acid receptors to infect bat cells, even though bat influenza A viruses do not appear to use these receptors for virus entry. Our results demonstrate that bats are unique hosts that select for both a novel mutation and a well-known adaptive mutation in the viral polymerase to support replication. 
I
nfluenza A virus (FLUAV) infects a broad range of mammalian and avian hosts (1, 2) . Transmission of FLUAV from natural reservoirs (migratory water fowl) to domestic hosts (poultry and pigs) and ultimately into the human population routinely involves the mutation of viral genes, the exchange of genes between viruses during the process of reassortment, or both (3) (4) (5) . Pigs, susceptible to both avian and human influenza A viruses, function as mixing vessels for these evolutionary processes that have resulted in viruses causing human pandemics. A defining feature of the porcine mixing vessel is the ability to be infected by both human and animal influenza A viruses. Therefore, birds and pigs are central to any FLUAV surveillance efforts. However, results from several recent studies have revealed a reservoir much broader and a pattern of cross-species transmission more complex than those that were previously appreciated: identification of nonhuman primates naturally infected by viruses closely related to human FLUAV (6) , natural infection and disease in domestic cats caused by highly pathogenic avian H5N1 viruses (7, 8) , transmission of H3N8 equine FLUAV into dogs that evolved into a lineage of canine influenza A virus that causes severe respiratory disease (9) , a distinct lineage of avian influenza virus in Antarctic penguins (10) , a potentially new genus for orthomyxoviruses in pigs and cattle distantly related to influenza C virus (11) , and identification of harbor seals and farmed guinea pigs infected by both FLUAV and influenza B virus (FLUBV) (12) (13) (14) (previously, FLUBV was thought to exclusively infect humans [15] ). Amplifying these reports, the recent detection of highly divergent FLUAVs in bats revealed a potentially vast new host range, as bats (order Chiroptera) comprise Ϸ20% of all classified mammals (16) (17) (18) (19) .
Bats are natural reservoirs for a wide variety of viruses (20, 21) , including many important zoonotic viruses that can cause severe disease, such as the filoviruses Marburg and Ravn (22, 23) , the paramyxoviruses Hendra and Nipah (24, 25) , and coronaviruses (CoVs) closely related to Middle Eastern respiratory syndrome (MERS)-CoV and severe acute respiratory syndrome (SARS)-CoV (26) (27) (28) (29) (30) . Very recently, bats have been shown to harbor hepaciviruses, hepadnaviruses, paramyxoviruses, and pegiviruses, which may be the ancestors of the hepatitis C, hepatitis B, mumps, and GB viruses currently circulating in humans, respectively (31-33). These findings suggest that bats harbor many viruses known to spill over into humans, and in some cases this spillover may involve complete host switching between bats and other mammals (34) .
Two new lineages of FLUAV, H17N10 and H18N11, have recently been identified in New World bats (16, 17) . H17N10 and H18N11 are the first known bat FLUAVs and were detected in microbats that belong to separate genera and that were sampled over 3,000 km apart. Phylogenetic analysis revealed these two viruses to be highly divergent from other extant FLUAVs, indicating an ancient origin coupled with long-term transmission and evolution in bats. Although isolates of these viruses have not yet been reported, for public health it is important to determine the potential of bats to serve as reservoirs or to be infected by human or avian viruses and act as mixing vessels for FLUAV variants capable of (re)entering the human population.
To infect a new host, FLUAV must overcome significant barriers to cross-species transmission and replication. Whereas proteins encoded on all eight genomic RNA segments of FLUAV have been implicated in this process, the dominant contributors are the segments encoding the cell surface hemagglutinin (HA) and the RNA-dependent RNA polymerase (RdRP) complex (1, 35, 36) . HA mediates the attachment and entry of virions into cells by binding sialic acid moieties on the host cell surface. Species-specific variations in the sialic acid structures create a major barrier to cross-species transmission that is overcome by adaptive HA mutations (37) (38) (39) . The viral neuraminidase (NA) protein also binds sialic acids, cleaving the glycan to facilitate release and prevent the self-aggregation of virions. The specificity of NA evolves along with HA to recognize species-specific sialic acid variants (40, 41) . Importantly, biochemical analyses indicate that bat FLUAV-derived H17 and H18 proteins do not bind sialic acids typically used by known FLUAV variants or any of more than 600 glycans tested (17, 42) . Moreover, the bat FLUAV NA-like proteins N10 and N11 lack sialidase activity (17, 43, 44) . The structures of bat HA-and NA-like proteins reveal highly divergent receptor binding sites, likely contributing to their altered target specificity (17, (42) (43) (44) (45) .
The FLUAV RdRP, composed of subunits PB1, PB2, and PA, associates with genomic RNA and the viral nucleoprotein (NP) to form ribonucleoprotein (RNP) complexes that mediate transcription and replication (46) . Unlike the replication of most other RNA viruses, the replication of FLUAV occurs in the nucleus of the host cell. RdRPs derived from avian FLUAV generally function poorly in human cells (47, 48) , with data suggesting the presence of a potent restriction factor present in human cells that selectively impairs polymerase function (49) . Restricted RdRPs cannot support efficient virus replication due to inhibition of RNP formation and subsequent genome transcription and replication, although the enzymatic activity of the complex appears to be largely unaffected (49) (50) (51) (52) . A single mutation in the PB2 subunit, conversion of the avian signature glutamic acid residue at position 627 to the human signature lysine residue (E627K), is sufficient to overcome FLUAV restriction in human cells (47, 49, 50, 53, 54) . Other FLUAV restriction escape mechanisms include second-site suppressor mutations and alterations in the nuclear import sequence of the PB2 subunit, as well as reassortment involving the PA subunit (36, (55) (56) (57) (58) (59) . Reassortment of genes in the viral replication machinery (i.e., PB1, PB2, PA, and NP) contributed to the emergence of pandemic FLUAV strains in 1957, 1968, and 2009 (60-62) . The restrictive FLUAV barriers present in bats, if any, and the relationship of these barriers to viral host range and the potential for bats to be reservoirs are unknown.
A critical question is whether FLUAV can move back and forth between humans and bats and which barriers are faced in a heterotypic host. Transmission of viruses from bats into humans has precedents and can be fatal in the case of diseases caused by Marburg virus, Hendra virus, Nipah virus, and SARS-CoV (22) (23) (24) (25) (26) (27) 29) . Similarly, FLUAV has crossed into humans and then back into mixing vessels. The 2009 H1N1 human influenza pandemic originally emerged from infected pigs and was subsequently transferred back to naive pigs by infected humans (60, 62, 63) . Results presented here show that cells from a large number of bat species were susceptible to human FLUAV and that no intrinsic blockade existed at the cellular level to prevent infection by human viruses in bats. Rather, our results indicate that FLUAV quickly adapted in bat cells to replicate to high titers in a new potential host. These findings highlight the importance of defining the full scope of mixing vessels and viral reservoirs that contribute to human disease.
MATERIALS AND METHODS
Cells. MDCK, MDBK, HEK293T, DF-1, and PK(15) cells (ATCC, Manassas, VA) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS). HA-MDCK cells were grown in DMEM supplemented with 10% FBS and 0.2 mg/ml hygromycin B (64) . LMH cells (a gift from D. Loeb) and Calu-3 cells (a gift from R. Baric) were grown in DMEM-Ham's F-12 medium (DMEM/F-12) supplemented with 5% and 20% FBS, respectively. The bat cell lines used in this study are described in Table 1 . The R05T, R06E, and HypNi/1.1 cell lines were grown in DMEM/F-12 supplemented with 10% FBS, Tb 1 Lu cells were grown in DMEM or minimal essential medium alpha (Mediatech, Inc., Manassas, VA) supplemented with 10% FBS, and all other bat cell lines were maintained in DMEM supplemented with 10% FBS. All cells were grown at 37°C in 5% CO 2 .
Plasmids. Plasmids carrying FLUAV RdRP proteins and NP were derived from FLUAV strains A/WSN/33 (H1N1; here abbreviated WSN), A/green-winged teal/OH/175/86 (H2N1; S009), A/Brevig Mission/18 (H1N1; 1918), A/Udorn/72 (H3N2; Udorn), A/New York/312/2001 (H1N1; NY312), and A/Utah/1/2009 (H1N1; UT1) and have been described previously (49, 55, 65) . A/little yellow-shouldered bat/Guatemala/ 164/2009 (H17N10; Guat164) genes were synthesized by GeneArt (Life Technologies, Grand Island, NY). The PA gene was cloned to express a PA with a FLAG epitope tag at the C terminus. pCDNA6.2-HA was used to express HA cloned from the WSN strain. The vNA-Luc reporter plasmid was used to express a minus-sense luciferase (Luc) gene flanked by the untranslated regions derived from WSN viral NA (vNA) using a polymerase I (polI) promoter and terminator (49, 66) . The virus rescue plasmid pTM-⌬RNP (55) was derived from pTM-All (a gift from Y. Kawaoka [67] ), used to express HA, NA, M, and NS viral RNAs (vRNAs) from the WSN strain. pBD-PB1, -PB2, -PA, -NP, -NA, -M, and -NS contained bidirectional polI and polII cassettes to express both vRNA and mRNA (49, 68) . pPOLI-HA(45)GFP (69) was a kind gift from P. Palese (64) . Mutant constructs were created by PCR-based strategies and confirmed by sequencing.
Viruses. Wild-type (WT) and reassorted WSN viruses were rescued by cotransfecting a coculture of HEK293T and MDCK cells with pTM-⌬RNP and the pBD plasmids using the TransIT-2020 transfection reagent 4 cells/well. One day later, the medium was removed and the cells were washed once with DMEM without FBS (0% DMEM). The cells were then infected with the single-cycle GFP-expressing WSN at a multiplicity of infection (MOI) of 0.2, 0.5, 2, or 5. After 1 h of incubation at 37°C, the viral inocula were removed and the cells were washed once with 0% DMEM and then supplemented with DMEM containing 2% FBS (2% DMEM). At 24 h postinoculation, one set of cells was fixed with 4% paraformaldehyde. GFP-positive cells were detected using high-content imaging (Operetta; PerkinElmer, Waltham, MA). The other set of cells was trypsinized and transferred to round-bottom 96-well plates. The percentage of GFP-positive cells was measured by fluorescence-activated cell sorting.
For viral entry studies, Brazilian free-tailed bat Tb 1 Lu cells were treated with receptor-destroying enzyme (RDE) or mock treated for 1 h prior to infection. RDE contained in Vibrio cholerae filtrate (Sigma-Aldrich, St. Louis, MO) was added at 5 l/ml to medium supplemented with 100 g/ml CaCl 2 . Tb 1 Lu cells were infected with single-cycle GFP-expressing WSN reporter virus, a VSV-G-pseudotyped influenza virus expressing GFP (FVG-G), or VSV expressing GFP and imaged at 20 h postinoculation.
RdRP activity assays. HEK293T, LMH, or DF-1 cells were transfected in triplicate with plasmids carrying the PA-FLAG, PB1, PB2, and NP genes and the vNA-Luc reporter plasmid. Reassorted polymerases were created by exchanging subunits between human, bat, and avian isolates. The cells were lysed 24 to 48 h later in cell culture lysis reagent, and luciferase activity was measured using the luciferase assay system (Promega, Madison, WI). PA expression was confirmed by Western blotting.
Multicycle replication assays. Cells were infected in triplicate at the MOI indicated below in VGM or DMEM/F-12 VGM with 0.25 g/ml TPCK trypsin, as appropriate. Infections in LMH, PK (15) , and Tb 1 Lu cells were performed at 37°C. Infections in Calu-3 cells were performed at 33°C. The viral titers of aliquots taken throughout the infection were determined by plaque assay in MDCK cells.
Experimental evolution. Tb 1 Lu cells were initially infected with FLUAV (WT or reassortant WSN virus carrying the avian S009 RNP [WSN-S009 RNP]) at an MOI of 0.1. At 48 to 72 h postinoculation, virus was passaged blindly onto fresh Tb 1 Lu cells using a 1:10 to 1:100 dilution of viral supernatant for nine serial passages. Titers for passages 2 to 9 were determined by plaque assay on MDCK cells after all of the passaging had been completed and indicated that passages were performed at an MOI of Ϸ0.1. A final high-titer stock was created at the 10th passage.
Metabolic labeling. Tb 1 Lu cells were infected with FLUAV at an MOI of 1 for 9.5 h, transferred to medium lacking cysteine and methionine for 1 h, and subsequently labeled for 1.25 h with [
35 S]Cys/Met EXPRE 35 S 35 S protein labeling mix (PerkinElmer). Whole-cell lysates were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the gels were dried, and proteins were detected by phosphorimaging.
Deep sequencing. Viral cDNA was generated from viral stocks and samples from passages 6 and 9 as described previously (73) . Individual FLUAV gene segments from each sample were gel purified, quantitated, and pooled in equimolar amounts into a single reaction mixture. Samples were fragmented, indexed with a Nextera DNA sample preparation kit, and sequenced on a MiSeq platform (Illumina, San Diego, CA). Sequence data were analyzed with the CLC Genomic Workbench (v.4.5.1; CLC Bio, Aarhus, Denmark). Sequence reads were deconvoluted and trimmed using a quality limit threshold of 0.001. Only reads greater than 100 bp in length were retained. Reads were mapped to full-length reference sequences from the cDNA clones used during the initial rescue of the parental virus (WSN) or WSN carrying the S009 RNP. SNPs were called at mapping sites with a greater than 100ϫ coverage, a central base Phred quality score of Q30 or greater, and a frequency at or above 1%. High-frequency mutations found in the deep sequencing of adapted viruses were introduced into recombinant viruses that were used to infect Tb 1 Lu cells.
Statistical analysis. Experiments were performed in triplicate or more. Data are presented as the mean Ϯ standard deviation (SD). Results from polymerase activity assays were normalized to those for the homotypic polymerase for each isolate, and error was propagated throughout the normalization. Statistical significance was determined by an unpaired two-tailed Student's t test.
RESULTS

Replication of human influenza A virus in bat cells.
The discovery of unique FLUAV variants in New World microbats raised the possibility that bats may influence the dissemination of FLUAV to other mammals by acting as direct reservoirs or mixing vessels for the generation of reassortants (16, 17) . To determine if bats could function as mixing vessels, we first assessed whether diverse bat cell lines are susceptible to infection with the prototypical mammalian H1N1 FLUAV A/WSN/33 (WSN), a laboratory-adapted human isolate. Bat cell lines were exposed to a single-cycle green fluorescent protein (GFP) reporter (GFP-WSN) virus at increasing multiplicities of infection (MOIs) (Fig. 1) (74) . All cell lines tested were susceptible to infection with GFP-WSN virus to some degree. Similar to control infections in dog kidney (MDCK) cells, the percentage of infected cells mostly increased with increasing MOI. The apparent decrease in GFP-positive cells detected by microscopy for infections in R06E cells resulted from the high degree of cytopathic effect, cell death, and detachment from the growth surface, even though fluorescence-activated cell sorting analysis showed that nearly all of the cells present were infected when a high MOI was used. In this sample, the size of which was limited, the cell lines derived from frugivorous African bats were significantly more susceptible than those derived from insectivorous American and Eurasian bats. Specifically, at most only Ϸ8% of the cells were infected in the case of the American Tb 1 Lu and B5L lines and the Eurasian MyDauLu/47.1 line when exposed to a high MOI of 5, whereas two African bat cell lines (R05T, EpoNi/22.1) were infected at rates approaching 100%. These results concur with those in recent reports of avian, swine, and human FLUAV infections in bat cell lines more limited in number than that tested in the present study (75, 76) .
A single-cycle GFP reporter FLUAV was initially used to test a large number of conditions. We subsequently infected Tb 1 Lu cells with the replication-competent WSN strain to determine if this bat cell line can support the entire replication cycle of a human FLUAV. As Tb 1 Lu cells were relatively refractory to infection ( Fig. 1) , infection was initiated with an MOI of 0.1, which is relatively high for multicycle replication (Fig. 2) . Viral titers increased over the course of the infection, exceeding 0.5 ϫ 10 6 PFU/ ml. In addition to the WSN lab strain, the primary human isolates The FLUAV RdRP is a key determinant of host tropism and pathogenicity (36, 46, 61) . We therefore tested the replicative capacity of viruses carrying RNP proteins from a primary human and avian FLUAV strains in Tb 1 Lu cells, A/New York/312/2001 (H1N1; NY312) and A/green-winged teal/OH/175/1986 (H2N1; S009), respectively (Fig. 2) . The remaining genes were derived from the WSN strain to control for the variability that might be introduced by the differential receptor usage of human and avian viruses and focus on phenotypes primarily caused by the RNP genes. The PB2 subunit from the NY312 isolate carries the human signature K627, whereas that from the S009 isolate carries the avian signature E627. We and others have previously shown that replication of the S009 reassortant virus is selectively restricted in human cells but not avian or swine cells, consistent with the species-specific defect in polymerase activity attributed to PB2 E627 (55, 77) . Virus carrying the NY312 RNP replicated similarly to WSN in Tb 1 Lu cells, reaching high titers within 24 h postinoculation (Fig. 2) . Conversely, replication of the virus carrying the S009 RNP was dramatically impaired in these cells, with minimal replication being evidenced by a constant low-level viral titer. The titers of the S009 RNP virus were Ϸ3 log units lower than those of the WSN and NY312 RNP viruses. This contrasts with the highly efficient replication of the S009 RNP virus in avian cells where the polymerase and host are matched (55) , indicating that this virus is not generically impaired. These data indicate that, akin to other mammalian cells (61) , bat cells are a restrictive environment for the activity of an avian-origin FLUAV RdRP. Together, these data demonstrate that all of the host machinery required by human FLUAV to bind, enter, and express viral genes is present in diverse bat cells and that Tb 1 Lu cells are also capable of at least producing infectious virions. The bat FLUAV ribonucleoprotein complex possesses a limited reassortment capacity. Reassortment is frequently associated with an increasing host range and the emergence of pandemic viruses. Coinfection of bat cells with human and porcine H1N1 strains produced novel progeny virus reassortants, but it is not known if genes from bat FLUAV can reassort with other strains (75) . A prerequisite for FLUAV genome reassortment is compatibility among the genes and gene products derived from different viruses. We therefore assessed the activity of reassortant FLUAV RdRPs containing components derived from human, avian, and bat viruses using a cell-based polymerase activity assay. The homotypic bat RNP containing subunits from A/bat/Guatemala/ 164/2009 (H17N10; Guat164) is highly active in human cells (Fig.  3A) (16, 17) . Heterotypic RdRPs were created by individually exchanging the PB1, PB2, or PA subunit from the Guat164 RdRP with the PB1, PB2, or PA subunit from the human isolate WSN, NY312, A/Brevig Mission/1918 (H1N1; 1918), A/Udorn/1972 (H3N2; Udorn), or A/Utah/01/2009 (H1N1; UT1) RdRP or the avian isolate S009 RdRP (Fig. 3A) . The enzymatic activity of all heterotypic RdRPs with human FLUAV subunits was reduced by a factor of at least 1,000. Only the avian S009 PB1 reassortant was marginally functional, retaining Ϸ5% the activity of the homotypic Guat164 RdRP.
We next tested whether human-and avian-derived FLUAV RdRPs could tolerate the introduction of individual bat-derived components. Polymerase activity was reconstituted with RNP subunits from WSN, NY312, 1918, UT1, Udorn, or S009, and heterotypic RdRPs were created by substituting components of the Guat164 RdRP (Fig. 3B) . Enzymatic activity was normalized to that of the homotypic complex for each isolate, although the absolute activity of the avian S009 RdRP was severely restricted in human cells compared to that of the human RdRP, as previously published (55, 56) . RdRP activity for most of the reassortants was appreciably compromised regardless of which RdRP subunit gene was exchanged; activity was reduced 20-to 1,000-fold compared to that of the homotypic RNPs. However, introducing Guat164 PA into the restricted avian S009 RdRP increased the activity by 4-fold.
PA reassortants can overcome the restriction of avian RdRPs in human cells (55, 56) . We therefore further tested RdRP activity in avian cells to determine if the increased activity of the S009 reassortant containing the Guat164 PA subunit resulted from a generic enhancement of polymerase activity or a selective alleviation of avian polymerase restriction in human cells. Introducing bat PA into human and avian RdRPs reduced their activities in avian LMH cells (Fig. 3C) . Western blotting confirmed that bat PA was expressed to equivalent levels in all RdRP activity assays. To exclude the possibility that the reassortants were defective because the Guat164 PA subunit does not function in avian cells, we confirmed that the homotypic bat RdRP and NP successfully reconstitute polymerase activity in avian cells (data not shown). Combined with the results from the RdRP activity assays in human cells, these data imply that bat PA partially alleviates the restriction of avian FLUAV RdRP in human cells. Thus, bat PA may increase the activity of an avian RdRP in a cell type-specific fashion, although most combinations of bat, human, and avian RdRP components impair activity, suggesting a limited capacity for reassortment between the known bat strains and other FLUAVs. The activity of human-and avian-origin polymerase complexes or heterotypic polymerase complexes containing individual bat subunits was determined as described in the legend to panel A. Activity was normalized to that of the homotypic RdRP for each isolate and is expressed as a percentage of wild-type activity. The PA subunit was detected by Western blotting. (C) Activity of RdRPs containing a homotypic or bat PA subunit in avian LMH cells was determined as described in the legend to panel B. Data are reported as the mean Ϯ SD (n ϭ 3).
Experimental adaptation of influenza A virus to replication in bat cells.
To understand how FLUAV adapts to replication in unique cellular environments, we experimentally selected for efficient FLUAV replication in Tb1 Lu cells, a cell line that was relatively resistant to infection (Fig. 1) . Two viruses, WSN and reassortant WSN carrying the avian S009 RNP, were evolved in parallel by blind passaging a 1:10 to 1:100 dilution of infected culture supernatant (MOI, Ϸ0.1) onto fresh Tb 1 Lu cells every 48 to 72 h for nine sequential rounds of infection (Fig. 4A) . In agreement with our previous results (Fig. 2) , WSN virus replicated at much higher levels than virus carrying the restricted S009 RNP. Titers for WSN remained relatively constant over 5 passages and then showed a marked 65-fold increase at passage 6. Subsequent passages yielded similarly high viral titers. Titers for WSN carrying the S009 RNP also increased throughout the experiment, beginning at passage 4. Despite increasing titers, this reassorted virus did not achieve the high levels detected for WSN virus. As the adaptation proceeded, the passaged virus began to induce cytopathic effects in the infected cells (Fig. 4B) . In contrast, cells infected with the parental virus were indiscernible from mock-infected cells, with the observed cell retraction being due to the trypsin present in the virus growth medium (VGM) that was absent in the control cells. These results demonstrate that FLUAV evolves during serial passaging to replicate more efficiently and with greater cytopathogenicity in bat cells.
The increased replication and cytotoxicity of the adapted viruses could result from changes to any stage of the viral life cycle. To obtain a global overview of viral gene expression, Tb 1 Lu cells were metabolically labeled after inoculation with either the parental or the adapted virus (Fig. 4C) . Protein expression levels in cells infected with the parental virus were marginally different from those in the uninfected control cells. Small amounts of NP and the comigrating M1 and NS1 proteins above the background amounts were discernible only in cells infected with WSN and not (Fig. 4D) . Both parental and bat-adapted WSN replicated in all three cell types, whereas the adapted viruses reached peak viral titers 10-to 100-fold lower than those of the controls (P Ͻ 0.05 for all cell types beginning at 48 h postinoculation). Taken together, these results show that experimental evolution of FLUAV in bat cells results in virus with increased replication, cytopathogenicity, and viral gene expression in cells from the selection host at the cost of reduced replication in cells from the corresponding homotypic host.
Mutations in the viral polymerase mediate adaptation. FLUAVs isolated from bats are extremely divergent from all other sequenced strains (16, 17) . Phylogenetic analysis places the bat FLUAV genes, with the exception of HA, as monophyletic outgroups to all other extant FLUAV genes. These genes diverged from those in the remaining FLUAV strains following the split from influenza B virus but before the diversification of FLUAV, indicating an ancient origin of the bat viruses. Furthermore, supporting a deep evolutionary divergence, the diversity found between select genes of the two bat FLUAV strains surpasses that found within all other FLUAV strains (17) . The evolutionary distance between human and bat FLUAVs makes it challenging to predict which differences between these viruses, our adapted viruses, and their parental counterparts might contribute to differences in replication in bat cells. Therefore, the adapted and parental viruses were deep sequenced to identify the genetic basis underlying the adaptive phenotype. Input virus and samples from passages 6 and 9 were analyzed, and their sequences were compared to the sequences of the cDNA clones used during the initial rescue of the parental virus ( Table 2) . Sequences of parental stocks of both WSN and WSN carrying the S009 RNP were extremely homogeneous, lacking nucleotide diversity above a threshold of 1% (i.e., at each nucleotide position with over 100ϫ coverage, less than 1% of all of the reads differed from the consensus residue), as would be expected for low-passage-number stocks that were rescued from cDNA clones.
As adaptation progressed, multiple nonsynonymous single nucleotide polymorphisms (SNPs) emerged in both viruses. SNPs were detected in PB2, PA, NP, and NS1 (Table 2) . Most coded for amino acid residue changes that had not been previously associated with host adaptation (36) . With the exception of the WSN PA G1597A SNP, these variants were retained and the majority increased in frequency by passage 9. Sequencing of the WSN-S009 RNP reassortant from passage 9 also revealed new SNPs in NS1, PA, and PB2.
None of the mutations present in the adapted viruses mapped to HA. This was unexpected, as HA frequently acquires changes to recognize species-specific variations in the sialic acid receptors used during viral entry (37) (38) (39) . Moreover, the H17 and H18 proteins of FLUAV isolated from bats do not appear to use for virus entry the canonical sialic acids that are used by other influenza A viruses (17, 42, 45 ), yet the successful infections shown here were performed with the WSN isolate, which recognizes ␣2,6-sialosides and, to a much lesser extent, ␣2,3-sialosides (79). To determine if WSN uses sialic acid as a receptor for entry into bat cells, Tb 1 Lu cells were treated with receptor-destroying enzyme (RDE) or mock treated prior to infection with single-cycle GFP-WSN reporter virus. The neuraminidase activity in RDE nonspecifically removes sialic acid moieties. Although Tb 1 Lu cells were relatively resistant to infection with human FLUAV compared to the other bat cell lines, these cells were used as they are derived from the Brazilian free-tailed bat, whose geographic distribution overlaps the sites where both the H17N10 and H18N11 viruses were identified (Guatemala and Peru, respectively) (16, 17) . Treatment with RDE prevented infection of Tb 1 Lu cells with the single-cycle GFP-WSN reporter virus, whereas infection was unchanged in mock-treated cells (Fig. 5 , No RDE). In parallel experiments, RDE-or mock-treated cells were infected with VSV-G-pseudotyped influenza virus carrying GFP (FVG-G) or VSV carrying GFP. RDE treatment had no effect on Tb 1 Lu cells infected with FVG-G or VSV, both of which enter cells independently of sialic acid receptors. Together, these results demonstrate that the canonical sialic acid receptors are present on bat cell lines and functional for entry of FLUAV. However, we cannot exclude the possibility that alternative receptors must be used to infect the appropriate target cell in vivo or that mutations in WSN HA would be necessary for transmission or infection in an animal. Nine of the 11 mutations in the adapted viruses mapped to the viral replication machinery. Remarkably, the canonical PB2 E627K mutation associated with the adaptation of avian FLUAV RdRPs to mammalian hosts was detected in S009 PB2 and fixed completely by passage 6 (Table 2) (47). This polymorphism was absent from the parental stocks (i.e., it was present at a level below the level of detection). The G1879A mutation encoding E627K detected here differs from S009 mutations that we had generated for use in previous experiments, precluding the possibility of contamination as the source. The evolution of S009 PB2 K627 is consistent with the restrictive phenotype that we have characterized for Tb 1 Lu cells (Fig. 2) and parallels the emergence and complete fixation of PB2 K627 in only 6 days during mouse infections with an avian H5N1 isolate (80) .
We constructed a series of mutant viruses to test the role of PB2 627 mutations during virus replication in Tb 1 Lu cells (Fig. 6A) . To create a human-like RdRP, the S009 RdRP was mutated to carry both PB2 K627 and the G590S/Q591R (SR) polymorphism that contributed to the 2009 influenza pandemic (55, 69) . Conversely, an avian virus-like polymerase was introduced into WSN by mutating PB2 to E627. These mutant viruses, along with their wild-type counterparts, were used to initiate infections in Tb 1 Lu cells. Viruses carrying RNPs from WSN and NY312 replicated to moderately high titers, whereas the virus carrying the S009 RNP was severely attenuated. The PB2 mutations completely converted the restriction phenotype. The humanized virus carrying S009 RNP replicated to levels similar to those of WSN and NY312 strains, whereas the avian virus-like WSN strain was restricted, like the virus carrying the S009 RNP. Thus, mutations at PB2 position 627 control replication ability in bat cells, reinforcing the role of this region as a major regulator of FLUAV tropism in birds versus mammals.
Four other nonsynonymous polymorphisms were found at a high frequency in RNP subunits: NP S245G, PB2 I518V, PA M285K, and PA D396G ( Table 2 ). The NP G245 and PB2 V518 mutations are present in all currently known bat FLUAV isolates. PB2 V518 predominates in other FLUAV isolates as well and was not pursued further. However, none of the PA mutations were present in bat FLUAV RdRP subunits and were exceedingly rare in subunits of other sequenced isolates (data not shown). The enrichment of NP S245G, PA M285K, and PA D396G during passaging could result from positive selection or represent hitchhiking. We therefore rescued recombinant FLUAV carrying these mutations alone or in combination and infected Tb 1 Lu cells. As in previous experiments, the parental WSN virus yielded titers almost 1,000-fold lower than those of the bat-adapted virus (Fig.  6B) . Viruses carrying NP S245G or PA D396G were further impaired and replicated at levels at least another 10-fold lower than those for the parental WSN virus. In contrast, virus carrying only the PA M285K change replicated to high levels and had titers within 5-fold of those of the bat-adapted virus, almost completely phenocopying adaptation. Moreover, combining PA M285K with titer (log pfu/ml) the attenuating mutation NP S245G and/or PA D396G increased the replication of these viruses. These data identify PA K285 to be a potent enhancer of replication in Tb 1 Lu cells and a novel regulator of species-specific FLUAV replication.
DISCUSSION
The discovery of two ancient and diverse lineages of FLUAV in bats separated by Ͼ3,000 km over the course of 2 years implies the existence of a large, geographically dispersed cryptic reservoir for FLUAVs. As other viruses circulating in bats have spilled over into other mammals to cause disease outbreaks (20) , it is of great interest to determine the potential for bats to be a source of FLUAV capable of emerging in the human population. We assessed the capacity of bats to serve as mixing vessels of In contrast to mutation, reassortment between bat, avian, and human viral polymerase genes failed to reconstitute highly active complexes or increase their host range. Thus, bat cells possess all of the necessary host machinery to support the robust replication of human influenza viruses. As the most recent common ancestor of humans and bats lived Ϸ65 million to 100 million years ago (81, 82) , these findings suggest that human FLUAV and FLUBV exploit ancestral and well-conserved host factors during replication. Experimental adaptation in bat cells showed that the viral RdRP was a hot spot; 7 of the 11 identified mutations accumulated in the PB2 and PA subunits. The adaptive M285K mutation in PA revealed by experimental evolution in bat cells is highly unusual and was detected only once in over 23,000 viruses isolated from humans or animals (data not shown), even though the polymerase complex is a frequent target of mutation as FLUAV changes hosts (36) . The PA subunit has discrete N-and C-terminal domains and is essential for both transcription and replication of the viral genome. Like other FLUAV isolates, the N-terminal domain from the bat-origin H17N10 virus is an endonuclease important for viral transcription (83) . The PA C-terminal domain containing the M285K change is best characterized as the PB1 binding site (84) . Structures of this head-shaped domain reveal a "jaw" that encircles the extreme N terminus of PB1 (85, 86) . Residue 285 is located outside the PB1 binding site, and the region surrounding this residue has not been assigned a discrete function. The N terminus of PB1 extends toward residue 285. The PA M285K change may enhance PB1 binding by interacting with the well-conserved aspartate at the second residue of PB1. PB1 D2 is important for high-affinity interactions with PA (87), yet the direct effect of PA M285K on these processes is unclear. PA M285K is part of a growing number of variations in PA that increase replication in a species-specific fashion, including variations carried by PA of avian H5N1 and H7N9 viruses that crossed over into humans (56, 58, (88) (89) (90) .
The PB2 subunit has long been identified to be a host range determinant and a mediator of viral pathogenicity (48) . The avian PB2 subunit was also under strong selective pressure in bat cells; the E627K mutation was rapidly fixed in the avian-origin polymerase and conveyed enhanced replication and cytopathic effects. The acquisition of the archetypal lysine at position 627 in PB2 during adaptation in bat cells suggests that the mode of restriction present in bats is similar to that present in other mammalian hosts. The bat-origin FLUAV does not carry either K627 or E627 in the PB2 subunit but carries the highly unusual S627. Bat-origin FLUAVs are the only viruses known to have this mutation, yet this polymerase is not restricted and functions at high levels in both human and avian cells (Fig. 3 and data not shown) (16, 17) .
A potential contributor to the activity of bat polymerases in human cells is the presence of asparagine instead of the more common aspartate at residue 701 in bat-derived PB2 proteins. Residue D701 interacts with the bipartite nuclear localization signal of PB2 (91) . The D701N substitution disrupts this interaction and has previously been shown to selectively enhance the nuclear import of PB2 in mammalian cells (92) , replication in mice (59, 93) , and transmission in guinea pigs (94) . Neighboring PB2 residue 702 has also been implicated in host shifts. The amino acid present at position 702 was computationally identified as a signature residue indicative of avian (K702) or human (R702) viral origin (95) (96) (97) . The mammalian signature residue R702 is absent from bat PB2 proteins with S702. Thus, studies of bat PB2 residues 701 and 702 will be important to determine their impact on polymerase function. Such studies will determine whether these residue changes alone are sufficient for the observed high-level activity of bat-origin polymerases in human cells or, perhaps, whether this viral lineage carries an alternative escape mechanism that avoids restriction.
To our surprise, none of the mutations that arose during experimental evolution were in HA or NA. HA and NA frequently change before or during cross-species transmission to recognize host-specific variations in the sialic acid receptors used by the virus for attachment to the cell surface (37) (38) (39) (40) (41) . The HA of WSN, the virus used here, preferentially recognizes ␣2,6-sialosides (79). The stability of HA and NA during repeated replication cycles in bats suggests that the preferred receptor is present on these bat cells. This conclusion is supported by results showing that the enzymatic removal of sialic acid moieties from bat cells prevents infection by FLUAV but not viruses that utilize other entry pathways, including a pseudotyped FLUAV (Fig. 5) . Neither HA nor NA from bat strains H17N10 and H18N11 recognizes ␣2,6-sialosides, ␣2,3-sialosides, or any of the over 600 other glycans tested (17, (42) (43) (44) . FLUAVs use noncanonical pathways for sialic acidindependent entry, during which binding between cell surface Ctype lectins, such as DC-SIGN and L-SIGN, and glycans on the virion occurs (98) . Thus, H17 and H18 might recognize a highly unusual sialoside or utilize alternative receptors during infections with the bat isolates. Studies to determine whether similar receptor usage and patterns of adaptation occur during cross-species infection in intact organisms will be important, as in this setting FLUAV also has to evade mucosal and adaptive immunity to reach sufficient extracellular titers for further transmission.
The results presented here suggest that infections in evolutionarily diverse bats contribute to the broad host range and geographic distribution of FLUAV. Furthermore, the data demonstrate that bats represent a unique environment for FLUAV that rapidly enforces selective pressures on the viral polymerase for adaptive mutations that enhance viral replication. Thus, replica-tion in nontraditional hosts like bats may be an important source of evolution and diversification of FLUAVs. 
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